Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

This study has been terminated.
Sponsor:
Information provided by (Responsible Party):
Claus Normann, University Hospital Freiburg
ClinicalTrials.gov Identifier:
NCT00273624
First received: January 4, 2006
Last updated: May 12, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)